CF PharmTech, Inc. (HKG:2652)
Hong Kong · Delayed Price · Currency is HKD 34.52
-0.76 (-2.15%)
At close: Feb 13, 2026
CF PharmTech Market Cap
CF PharmTech has a market cap or net worth of 14.21 billion as of February 13, 2026.
Market Cap
14.21B
Enterprise Value
13.96B
Revenue
647.51M
Ranking
n/a
PE Ratio
477.71
Stock Price
34.52
Market Cap Chart
Since October 8, 2025, CF PharmTech's market cap has decreased from 15.86B to 14.21B, a decrease of -10.39%. That is a compound annual growth rate of -27.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 14.53B | 0.76% |
| Dec 31, 2025 | 14.42B | -9.11% |
| Oct 8, 2025 | 15.86B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| The United Laboratories International Holdings | 25.83B |
| Sunshine Lake Pharma | 25.53B |
| Ab&B Bio-Tech CO., LTD. JS | 19.49B |
| Consun Pharmaceutical Group | 15.33B |
| Sihuan Pharmaceutical Holdings Group | 15.16B |
| CanSino Biologics | 13.02B |
| Luye Pharma Group | 10.94B |
| China Traditional Chinese Medicine Holdings Co. | 10.37B |